Merck & Co., headquartered in Rahway, New Jersey, employs 72,000 people and provides health solutions through pharmaceuticals, vaccines, and animal health products. Its lead candidate is MK-6070, targeting DLL3.
MRK has been in the news recently: The FDA has approved Merck & Co. Inc.'s MRK Welireg for patients aged 12 and older with advanced pheochromocytoma or paraganglioma. Additionally, upcoming Medicare drug price negotiations by the Trump administration will affect companies like Merck and Bristol Myers Squibb.
📡️ Health Care
In The News
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
